Minimal variation in anti-A and-B titers among healthy volunteers over time: Implications for the use of out-of-group blood components

Journal of Trauma and Acute Care Surgery

Volumn 82, Issue 6, 2017, Pages S87-S90

  Sprogøe, Ulrik ^a   Yazer, Mark H ^a,b   Rasmussen, Mads Hvidkjær ^a   Antonsen, Berit ^a   Bistrup, Claus ^a   Assing, Kristian ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anti A; anti B; Plasma; Titer; Whole blood

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; BLOOD GROUP ABO SYSTEM; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; FEMALE; HUMAN; HUMAN EXPERIMENT; LONGITUDINAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; BLOOD; BLOOD COMPONENT THERAPY; BLOOD GROUP ABO SYSTEM; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; YOUNG ADULT;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; BLOOD COMPONENT TRANSFUSION; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85015938743     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000001432     Document Type: Article

References (23)

1. Dunbar NM, Yazer MH; Biomedical Excellence for Safer Transfusion Collaborative. A possible new paradigm? A survey-based assessment of the use of thawed group A plasma for trauma resuscitation in the United States. Transfusion. 2016;56:125-129.
2. Yazer MH, Jackson B, Sperry JL, Alarcon L, Triulzi DJ, Murdock AD. Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients. J Trauma Acute Care Surg. 2016;81:21-26.
3. Seheult JN, Triulzi DJ, Alarcon LH, Sperry JL, Murdock A, Yazer MH. Measurement of haemolysis markers following transfusion of uncrossmatched, low-titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre. Transfus Med. 2016;27:30-35.
4. Berséus O, Boman K, Nessen SC, Westerberg LA. Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion. 2013;53(Suppl 1): 114S-123S.
5. Rieben R, Frauenfelder A, Nydegger UE. Naturally occurring ABO antibodies: long-term stable, individually distinct anti-A IgG spectrotypes. Eur J Immunol. 1992;22:2129-2133.
6. Wiener AS, Samwick AA, Morrison H, Cohen L. Studies on immunization in man. I. The blood group substances A and B. Exp Med Surg. 1953;11: 267-275.
7. McShine RL, Kunst VA. The stimulation of immune antibodies anti-A and anti-B in patients after treatment with cryprecipitate and factor IX concentrate (P.P.S.B. according to Soulier). Vox Sang. 1970;18:435-440.
8. Boorman KE, Dodd BE, Mollison PL. Iso-immunisation to the blood-group factors A, B and Rh. J Pathol Bacteriol. 1945;157.
9. Miler JJ, Novotny P, Walker PD, Harris JR, MacLennan IP. Neisseria gonorrhoeae and ABO isohemagglutinins. Infect Immun. 1977;15:713-719.
10. Daniel-Johnson J, Leitman S, Klein H, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion. 2009;49:1845-1849.
11. Crawford H, Falconer H, Cutbush M, Mollison PL. Formation of immune A iso-antibodies, with special reference to heterogenetic stimuli. Lancet. 1952; 2:219-223.
12. Gupte SC, Bhatia HM. Anti-A and anti-B titre response after tetanus toxoid injections in normal adults and pregnant women. Indian J Med Res. 1979;70: 221-228.
13. Springer GF Influenza virus vaccine and blood group A-like substances. Transfusion. 1963;3:233-236.
14. Siber GR, Ambrosino DM, Gorgone BC. Blood-group-A-like substance in a preparation of pneumococcal vaccine. Ann Intern Med. 1982;96:580-586.
15. Delaney M, Warner P, Nelson K, Gleckler C, Price T, Madeleine M. Humoral immunomodulatory effect of influenza vaccine in potential blood donors: implications for transfusion safety. Transfus Med. 2011;21:378-384.
16. Karafin MS, Blagg L, Tobian AA, King KE, Ness PM, Savage WJ. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion. 2012;52:2087-93.
17. Tanabe K. Interinstitutional variation in the measurement of anti-A/B anti-bodies: the Japanese ABO-Incompatible Transplantation Committee survey. Transplantation. 2007;84:S13-S16.
18. Kumlien G, Wilpert J, Säfwenberg J, Tydén G. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation. 2007;84:S17-S19.
19. Cooling LL, Downs TA, Butch SH, Davenport RD Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets. Transfusion. 2008;48:2106-2113.
20. Duez A, Flourié F, Garraud O. Antibodies titration for immunized pregnant women: conventional tube test or gel microcolumn assay. Transfusion. 2014;54:1200.
21. Quillen K, Medrano C, Adams S, et al. Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome. Transfusion. 2011;51:504-510.
22. Novaretti MC, Jens E, Pagliarini T, Bonifacio SL, Dorlhiac-Llacer PE, Chamone DA. Comparison of conventional tube test with diamed gel microcolumn assay for anti-D titration. Clin Lab Haematol. 2003;25:311-315.
23. Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A, B: implications for transfusion policy. Transfusion. 2004;44:805-808.